Document is current
Any future updates will be listed below
-
Authors
Xue, Yan
Qin, Xianghong
Zhou, Liya
Lin, Sanren
Wang, Ling
Hu, Haitang
Xia, Jielai
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01107938 at ClinicalTrials.govDocuments that mention this clinical trial
A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis
https://doi.org/10.1007/s40261-016-0446-3
- License Information
-
More Information
Article History
First Online: 7 September 2016
Compliance with Ethical Standards
:
: The study was sponsored by Livzon Pharmaceutical Group Inc., China.
: The study was sponsored by Livzon Pharmaceutical Group Inc., China.
: Xianghong Qin is an employee of Livzon Pharmaceutical Group Inc. Yan Xue, Liya Zhou, Sanren Lin, Ling Wang, Haitang Hu, and Jielai Xia declare no conflicts of interest that affect the results of the study.
: This study was approved by the Ethics Committee of the Health Center of Peking University.
: All study participants provided written informed consent before being included in the study.
